Capecitabine and oxaliplatin in combination (Xelox) as first line therapy for patients (pts) with metastatic colorectal cancer (MCRC): results of an international multicenter phase II trial. - Tabernero,J.; Butts,C.A.; Cassidy,J. (Proc Am Soc Clin Oncol, 2002)